MEDANTA: Q2 growth and margin gains accompanied strong patient volumes and Noida EBITDA breakeven

What happened

In Q2 FY27, revenue grew 33.6% and Operating EBITDA rose 60.2%, with margin expanding to 25.2% and PAT up 38.3%. Volume growth, higher occupancy and Cluster 2 gains supported results, alongside Noida EBITDA breakeven.

Confirmed

Global impact / market context

Faster profit growth than revenue means more of each sale reaches the bottom line, helped by higher occupancy spreading fixed costs. Noida reaching EBITDA breakeven, which means operating profit before interest, tax and depreciation, stops that site from draining cash and improves group earnings quality.

Analyst inference

Hospitals carry heavy fixed costs, so rising patient volumes lift profit per sale quickly. Investors often watch whether such gains persist as new beds open. Strong Cluster 2 results and Noida breakeven suggest the expansion is starting to pay off rather than just adding costs.

Analyst inference

What to watch

1. Watch whether revenue growth of 33.6% and Operating EBITDA growth of 60.2% continue in coming quarters, since slower growth would weaken the operating profit per sale expansion. Confirmed
2. Track Noida's EBITDA after breakeven; management could show whether the site sustains positive operating profit or slips back as new capacity and staffing costs are added. Proposed
3. Monitor occupancy and patient volumes, because they drive hospital revenue and spread fixed costs; any dip would pressure margin, profit and cash available for expansion. Analyst inference

Evidence

• Original source link unavailable